Pediatric Plasmablastic Lymphoma in the Setting of CD70 Deficiency.

IF 0.9 4区 医学 Q4 HEMATOLOGY Journal of Pediatric Hematology/Oncology Pub Date : 2024-11-01 Epub Date: 2024-09-05 DOI:10.1097/MPH.0000000000002948
Kubra Baskin, Ozge Vural, Sule Haskologlu, Baran Erman, Pinar Uyar Gocun, Arzu Okur, Figen Dogu, Faruk Guclu Pinarli, Aydan Ikinciogullari
{"title":"Pediatric Plasmablastic Lymphoma in the Setting of CD70 Deficiency.","authors":"Kubra Baskin, Ozge Vural, Sule Haskologlu, Baran Erman, Pinar Uyar Gocun, Arzu Okur, Figen Dogu, Faruk Guclu Pinarli, Aydan Ikinciogullari","doi":"10.1097/MPH.0000000000002948","DOIUrl":null,"url":null,"abstract":"<p><p>Combined immunodeficiency due to CD70 deficiency is characterized by increased susceptibility to infections, hypogammaglobulinemia, and malignancy. These patients typically present with chronic Epstein Barr virus (EBV) viremia, severe EBV-related hemophagocytic lymphohistiocytosis, lymphoproliferation, and Hodgkin and non-Hodgkin lymphomas. Plasmablastic lymphoma (PBL) is an extremely rare malignancy in all ages and is predominantly seen in male adults with human immunodeficiency virus infection. EBV infection, immunosuppression, solid organ transplantation, and age-related immune deterioration are also suspected causes of PBL. Nevertheless, there is scarce data about its association with primary immunodeficiencies in the literature. Here, we present the first case of a CD70 -deficient pediatric patient with PBL.</p>","PeriodicalId":16693,"journal":{"name":"Journal of Pediatric Hematology/Oncology","volume":" ","pages":"438-441"},"PeriodicalIF":0.9000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pediatric Hematology/Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/MPH.0000000000002948","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/5 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Combined immunodeficiency due to CD70 deficiency is characterized by increased susceptibility to infections, hypogammaglobulinemia, and malignancy. These patients typically present with chronic Epstein Barr virus (EBV) viremia, severe EBV-related hemophagocytic lymphohistiocytosis, lymphoproliferation, and Hodgkin and non-Hodgkin lymphomas. Plasmablastic lymphoma (PBL) is an extremely rare malignancy in all ages and is predominantly seen in male adults with human immunodeficiency virus infection. EBV infection, immunosuppression, solid organ transplantation, and age-related immune deterioration are also suspected causes of PBL. Nevertheless, there is scarce data about its association with primary immunodeficiencies in the literature. Here, we present the first case of a CD70 -deficient pediatric patient with PBL.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
缺乏 CD70 的小儿浆细胞性淋巴瘤
CD70 缺乏症导致的联合免疫缺陷的特点是对感染、低丙种球蛋白血症和恶性肿瘤的易感性增加。这些患者通常表现为慢性爱泼斯坦巴氏病毒(EBV)病毒血症、严重的EBV相关性嗜血细胞淋巴组织细胞增多症、淋巴细胞增生以及霍奇金淋巴瘤和非霍奇金淋巴瘤。浆细胞性淋巴瘤(PBL)是一种极其罕见的恶性肿瘤,不分年龄,主要见于感染人类免疫缺陷病毒的成年男性。EB病毒感染、免疫抑制、实体器官移植以及与年龄相关的免疫功能衰退也是导致浆细胞性淋巴瘤的可疑原因。然而,文献中有关该病与原发性免疫缺陷相关的数据却很少。在此,我们介绍了首例 CD70 缺陷型 PBL 儿童患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
1.90
自引率
8.30%
发文量
415
审稿时长
2.5 months
期刊介绍: ​Journal of Pediatric Hematology/Oncology (JPHO) reports on major advances in the diagnosis and treatment of cancer and blood diseases in children. The journal publishes original research, commentaries, historical insights, and clinical and laboratory observations.
期刊最新文献
Atypical Teratoid Rhabdoid Tumor of the Brain in a Young Adult With Down Syndrome: Case Report and Literature Review. Elevated Interleukin-6 Levels as a Potential Marker of Neonatal Morbidity in Full-term Infants With Polycythemia: A Prospective Study. Case Report of Dinutuximab-induced Atypical Hemolytic Uremic Syndrome. Hepatoblastoma in a 13-month-old Male With Oculofaciocardiodental Syndrome. Retrospective Comparison of Targeted Anticancer Drugs Predicted by the CNS-TAP Tool Versus Those Selected by a Molecularly Driven Tumor Board in Children With DIPG.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1